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Edited by Berend WieringaAbstract Myosin-binding protein C (MyBPC) is proposed to
take on a trimeric collar arrangement around the thick ﬁlament
backbone in cardiac muscle, based on interactions between car-
diac MyBPC domains C5 and C8. We have now determined,
using yeast two-hybrid and in vitro binding assays, that the
C5:C8 interaction is not dependent on the 28-residue cardiac-
speciﬁc insert in C5. Furthermore, an interaction of similar aﬃn-
ity occurs between domains C5 and C8 of fast skeletal muscle
MyBPC, but not between these domains of the slow skeletal
muscle protein. These data have implications for the role and
quaternary structure of MyBPC in skeletal muscle.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Myosin binding protein C (MyBPC) occurs on the surface of
the thick ﬁlament of striated muscle in 7–9 of the 11 transverse
stripes in the C-zone of the sarcomere [1]. The cardiac isoform
of this protein (cMyBPC) has attracted particular interest, due
to the frequent involvement of its corresponding gene,
MYBPC3, in a common inherited cardiac muscle disease,
hypertrophic cardiomyopathy [2]. The modular protein con-
sists of 10–11 domains with either ﬁbronectin type III or
immunoglobulin (Ig) homology, and the characteristic
MyBPC-motif located between the N-terminal domains C1
and C2. The functions of some domains are known, suggesting
that, at least in cardiac muscle, MyBPC plays both a structural
and a regulatory role (reviewed in Ref. [3]).
We have previously shown that cMyBPC domain C5 specif-
ically interacts with cMyBPC domain C8 in vitro; these and
other data led us to propose a model for the quaternary
arrangement of cMyBPC within the sarcomere [4]. In this
model, three cMyBPC molecules consecutively dimerise, stag-
gered and in parallel, with the C5–C10 regions forming a col-
lar-like structure around the core of the thick ﬁlament, while
the C0–C4 region extended into the interﬁlament space.
Aside from an additional N-terminal domain, C0, the car-
diac isoform also diﬀers from the fast and slow skeletal iso-*Corresponding author. Fax: +27 21 9389476.
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domain C5; the latter insertion is unstructured and of un-
known function [5]. This unusual feature of domain C5 led
us to inquire whether the C5:C8 interaction is dependent on
the insertion sequence, or whether a similar interaction would
occur in slow (ssMyBPC) and fast skeletal MyBPC (fsMyBPC)
isoforms.2. Methods
2.1. Construct assembly and protein puriﬁcation
The regions encoding C5 (residues 642–772) and C8–10 (residues
977–1274) were cloned from a full length MYBPC3 cDNA. PCR-
mutagenesis was used to generate a ‘‘pseudoskeletal’’ C5 (psC5) do-
main in which the nucleotides encoding the 28-residue insertion were
deleted from cardiac C5 (Fig. 1). The regions corresponding to do-
mains C5 and C8–C10 of MYBPC1 (ssMyBPC; residues 547–646
and 843–1171) and MYBPC2 (fsMyBPC; residues 539–638 and 837–
1141) were ampliﬁed by PCR from human skeletal muscle cDNA
(Stratagene).
For the yeast constructs, ampliﬁed products of C5 were cloned in-
frame with the GAL4–DNA binding domain (GAL4BD) in CLON-
TECH bait vector pGBKT7 (cC5, ssC5, fsC5, and psC5). Similarly,
sequences encoding domains C8–C10 were cloned in-frame with the
GAL4-activation domain (AD) in CLONTECH prey vector pGADT7
(cC8–10, ssC8–10, and fsC8–10). As control bait vectors, pGBKT7
constructs encoding MYBPC3 domain C2 (residues 358–452), and
MYBPC1 and MYBPC2 domain C4 (residues 457–546 and 438–538,
respectively) were generated in the same manner. Additional control
vectors included unrecombined bait and prey vectors.
For bacterial over-expression, C5 and C8–10 sequences were cloned
into pET28a which provides an N-terminal hexahistidine tag. The do-
main fragments were obtained at >95% purity by Ni2+–NTA aﬃnity
and ion exchange chromatography, and dialysed into myosin binding
buﬀer (100 mM KCl, 20 mM imidazole pH 7.0, 1 mM dithiothreitol
(DTT)).
2.2. Yeast two-hybrid protein–protein interaction assays
Bait vectors were individually transformed into S. cerevisiae strain
AH109, and prey vectors into strain Y187, by a lithium acetate proce-
dure. Bait and prey lines from corresponding muscle types were mated,
and plated onto medium lacking leucine and tryptophan. Two separate
quantitative liquid b-galactosidase assays with O-nitrophenyl b-D-
galactopyranoside (ONPG) as substrate was performed with these dip-
loid colonies, each in triplicate, using a method described by Liu and
Welsh [6]. To combine results from the two experiments, each samples
b-galactosidase activity was indexed to the mean b-galactosidase levels
produced by the pGBKT7xC8C10 negative control for each muscle
type.
2.3. Surface plasmon resonance
The interaction between paired C5 and C8–10 fragments was studied
using surface plasmon resonance (SPR, BIAcore X) as described in our
earlier study [4]. Brieﬂy, C8–10 fragments were covalently coupledblished by Elsevier B.V. All rights reserved.
Fig. 1. ClustalW alignment of cardiac, fast and slow skeletal myosin binding protein C domain C5, showing diﬀerences in homology. The cardiac-
speciﬁc insertion (underlined) was removed for creation of a pseudoskeletal domain C5, using primers with homology to nucleotide sequences
corresponding to the shaded regions on either side of the insertion, but not to the insertion itself. The ‘‘linker region’’ between domains C4 and C5,
present only in cardiac and fast skeletal myosin binding protein C, is shown blocked. cMyBPC = human cardiac myosin binding protein C,
fsMyBPC = human fast skeletal muscle myosin binding protein C, ssMyBPC = human slow skeletal muscle myosin binding protein C.
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chip using the BIAcore amine-coupling kit (response unit (RU) in-
crease ca. 1000), the other ﬂow cell acting as control. Domain C5
(10–100 lM) in myosin binding buﬀer was injected at 20 ll/min for
150 s and dissociation data collected for at least a further 100 s. Equi-
librium binding constants were calculated using the BIAevaluation
software (BIAcore AB).3. Results
3.1. Y2H interaction assays
A set of GAL4BD fusion-protein constructs in pGBKT7 was
assembled for each C5 domain (cC5, ssC5, fsC5 and psC5).
Similarly, C8–10 domains (cC8–10, ssC8–10, and fsC8–10)
were cloned into pGADT7 to generate GAL4AD fusion-pro-
tein constructs. To assess the ability of the diﬀerent C5 iso-
forms to interact with their corresponding C8 domains,
protein–protein interaction was assessed by quantitative liquid
b-galactosidase assays in a yeast two-hybrid system. The b-
galactosidase production by psC5xcC8–10 was >2.5 times that
of cC5xcC8–10 diploid yeasts, which in turn was signiﬁcantly
higher than background control levels (pGBKT7xcC8–10,
cC5xpGADT7) as well as the cC2xcC8–10 control. Similarly,
fsC5xfsC8–10 diploid yeasts yielded signiﬁcantly higher b-
galactosidase levels than the relevant background controls
(pGBKT7xfsC8–10, fsC5xpGADT7), as well as the
fsC4xfsC8–10 control (Fig. 2A and B). In contrast, there was
no evidence for b-galactosidase production at higher than
background level by either the ssC5xssC8–10 or ssC4xssC8–
10 diploid yeasts (Fig. 2C).
3.2. In vitro aﬃnity measurements
The pairwise interaction of C5 and C8–10 domains was as-
sessed in vitro using our SPR-based assay and the binding
aﬃnities compared with the previously established cC5:cC8–
10 aﬃnity (Ka = 1.0 · 105 M1) [4]. The deletion of the 28-res-
idue insertion in cC5 did not interfere signiﬁcantly withbinding to cC8–10, as the psC5 bound to cC8–10 with similar
aﬃnity to cC5 (psC5:cC8–10 Ka = 1.3 · 105 M1 vs. cC5:cC8–
10 Ka = 1.0 · 105 M1) (Fig. 3A). To test whether the equiva-
lent skeletal muscle domains interact in a similar manner,
experiments were performed with fast and slow skeletal C5
and C8–10. The fast skeletal pair showed signiﬁcant binding
(Fig. 3B), with the measured aﬃnity higher than that of the
cardiac pairing (fsC5:fsC8–10, Ka = 5.7 · 105 M1). However
slow skeletal C5 and C8–10 interacted considerably less
strongly (Fig. 3C). It was not possible to generate an accurate
binding constant from the latter data, but the estimated Ka is
at least 10-fold lower than that of the cC5:cC8–10 interaction.4. Discussion
We previously proposed a collar model for the quaternary
arrangement of cMyBPC around the thick ﬁlament backbone,
based on our observations of speciﬁc interactions between do-
mains C5 and C8, and also between domains C7 and C10, of
cMyBPC, and with incorporation of previous ultrastructural,
biochemical and immunocytochemical data on myosin binding
proteins [4]. This model does not predict the arrangement of
domains C0–C4, but we speculated that this N-terminal half
of cardiac MyBPC may extend into the interﬁlament space,
facilitating interaction with myosin S2 and/or actin. As the
C5:C8 interaction was adversely aﬀected by the presence of
two HCM-causing missense mutations ﬂanking the cardiac-
speciﬁc insertion [4], the question was posed as to whether this
insertion sequence was responsible for the interaction.
Consequently, in this study we assessed the ability of cardiac
domain C5 lacking the insertion sequence to participate in this
interaction. We found that the C5:C8 interaction was not
dependent upon the presence of the insertion (Figs. 2A and
3A); the function of this sequence in cC5 therefore remains un-
clear. This unfolded insertion is proline/charged-residue rich,
and has been suggested to be involved in signaling, acting as
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Fig. 2. Quantitative b-galactosidase assays of domain interactions in (A) cardiac MyBPC, (B) fast skeletal MyBPC and (C) slow skeletal MyBPC.
One unit of b-galactosidase was deﬁned as the amount of enzyme that hydrolyzes 1 lmol of ONPG to O-nitrophenol and D-galactose per minute per
cell. Combined data from two separate experiments are shown, with each samples b-galactosidase activity indexed to the mean b-galactosidase levels
produced by the corresponding pGBKT7xC8C10 negative control.
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docking of the CaM-kinase that co-puriﬁes with MyBPC [7,8].
Based on these results, we tested whether similar interactions
occur between the corresponding domains of slow and fast
skeletal muscle isoforms. We found that fast skeletal domains
C5 and C8–10 bind at least as strongly as the cardiac equiva-
lents (Figs. 2B and 3B), thus suggesting that a similar trimeric
collar of MyBPC may exist in fast skeletal muscle. In contrast,
we found a considerably lower aﬃnity for the interaction be-
tween the corresponding ssMyBPC domains (Figs. 2C and
3C), suggesting that the proposed collar arrangement is either
considerably weaker or not present in slow skeletal muscle.
The full length fsMyBPC protein is slightly more homolo-
gous to cMyBPC than is ssMyBPC (55% and 50% homology,
respectively), and this is more evident over the regions of C5
(55% and 44% homology, respectively) than C8 (57% and
51%, respectively) used in this study. The ‘‘linker’’ region be-
tween domains C4 and C5, shown by Idowu et al. to form part
of the Ig structure of domain C5 [5], is also present only in car-
diac and fsMyBPC, but not in ssMyBPC (Fig. 1). However, as
this region was not incorporated into the constructs used inthis study, it is clearly not responsible for the C5:C8 interac-
tion noted in cMyBPC and fsMyBPC. Residues which are
identical between fsMyBPC and cMyBPC, but are not similar
between ssMyBPC and cMyBPC, are clustered in two regions:
the F and G beta-strands (with some loss of charge in
ssMyBPC), and the loop preceding beta-strand A 0 (Fig. 4).
In the latter region, H648, conserved identically in cMyBPC
and fsMyBPC, but replaced by an Ile in ssMyBPC, occurs
immediately opposite R654 (Fig. 4). This residue, when mu-
tated to H by an HCM-causing mutation, reduces the aﬃnity
of cC5 for cC8 [4]. These ﬁndings supports the suggestion by
Idowu et al. that the CFGA 0 sheet may be involved in the
cC5:C8 interaction, with the R654 providing speciﬁcity [5].
It is also noteworthy that fsMyBPC shares many of the bio-
chemical characteristics of cMyBPC. At physiological ionic
strength the sedimentation co-eﬃcient of fsMyBPC increases
with rising concentrations [9], consistent with dimerisation
and multimerisation of the protein, a phenomenon also
reported for cardiac MyBPC [10]. Puriﬁed fsMyBPC also takes
on a similar V-shaped structure as cMyBPC [10,11]. In
contrast, fewer comparable biochemical and ultrastructural
Fig. 4. Structure of cC5. Residues which are identical in fsMyBPC and
cMyBPC, but dissimilar in ssMyBPC, are indicated in yellow and
annotated, with the corresponding residues in ssMyBPC in brackets.
Beta-strands are shown as arrows, and the A 0, G, F and C strands as
well as the R654 residue, aﬀected by an HCM-causing mutation, are
annotated.
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Fig. 3. Measurement of the interaction of C5 and immobilised C8–10
domains by a surface plasmon resonance-based assay Diﬀerent C8–
C10 fragments were covalently immobilised onto a BIAcore B1 chip
and their interaction with soluble C5 fragments measured in buﬀer
containing 100 mM KCl, 1 mM DTT and 20 mM imidazole pH 7.0 at
25 C at a ﬂow rate of 20 ll/min. 50 ll (150 s) injections were
performed and dissociation of bound protein was monitored for at
least a further 100 s. Typical real time binding curves are shown for:
(A) pseudoskeletal cC5 and cC8–10; (B) fsC5 and fs C8–10; (C) ssC5
and ssC8–10.
E. Flashman et al. / FEBS Letters 582 (2008) 434–438 437data are available for ssMyBPC, previously called X-protein
[12], and thus the conformation of ssMyBPC in the sarcomere
remains speculative. One study reported the ability of X-pro-
tein to form long, ribbon-like polymers at low ionic strength,
and proposed that X-protein could polymerise, in vitro, by
means of end-to-end intermolecular binding [13].
FsMyBPC and ssMyBPC do not co-occur in slow or fast red
ﬁbres, and occur in diﬀerent transverse stripes in the C-zone of
fast white ﬁbres [14,15]. In contrast, in fast intermediate ﬁbres
from rabbit plantaris muscle, the same stripes labeled with
both slow and fsMyBPC antibodies. However, as the two types
of antibodies used in this simultaneous labeling experiment
could not be distinguished, it remains unclear whether slow
and fsMyBPC co-exist at the same myosin crown, or even in
the same sarcomere [14].
A number of very elegant modelling studies of X-ray diﬀrac-
tion data performed on ﬁsh ﬁn muscle [16,17] have allowed the
proposal of alternative models for the quaternary arrangement
of MyBPC with respect to the thick and thin ﬁlaments. How-
ever, these ﬁsh muscles consist of fast white, slow red and
intermediate pink ﬁbres, and the ratio of these ﬁbres types
changes with gender, season and water temperature [18,19].
Thus, whether the data arising from these experiments pertain
to ssMyBPC or fsMyBPC is unclear. Given the results of our
study, it may be that a generalized model for myosin binding
proteins within the thick ﬁlament cannot be derived from these
ultrastructural data unless the ﬁbre type used in a given exper-
iment is also resolved.
Fast skeletal muscle is typically required for strong contrac-
tions, and functions under anaerobic conditions. It diﬀers from
slow skeletal muscle, but is similar to cardiac muscle, in terms
of pCa50-indexed force development, length-dependent activa-
tion and length-independent cooperativity [20]. These similar-
ities may point to similar modes of action of fsMyBPC and
cMyBPC during contraction and relaxation. Partial extraction
of MyBPC resulted in increased active tension in both cardiac
and fast skeletal muscle at submaximal Ca2+-concentrations,
but did not aﬀect maximum tension, suggesting that in these
438 E. Flashman et al. / FEBS Letters 582 (2008) 434–438two muscle types, MyBPC modulates the range of movement
of myosin [21]. Similarly, the absence of cMyBPC in murine
cMyBPC knock-out models has correlated with impaired
relaxation, both under basal conditions and after adrenergic
stimulation, and studies on these animals have suggested that
cMyBPC participates in regulation of cardiac contractility at
short sarcomere length [22].
Taken together, these data suggest that in cardiac and fast
skeletal muscle, MyBPC may contribute to an internal load,
perhaps by binding to actin via its N-terminal region, or
else by inﬂuencing the mechanical properties of myosin
cross-bridges [23–25]. This is consistent with the ﬁnding that
cross-bridge mechanics and kinetics, rather than thin ﬁlament
inactivation kinetics, are the principle determinants of relaxa-
tion rate in striated muscle [26]. Further functional and ultra-
structural studies with known ﬁbre type will be required to
establish both the arrangement and the role of slow skeletal
MyBPC in muscle contractility, while the biological function
of the cardiac-speciﬁc insertion in domain C5 remains to be
elucidated.
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